To rule out the possibility that the effect of TUSC2 and MK2206 combined treatment could be a cell line or a gene-specific effect, we used multiple TUSC2-deficient NSCLC cell lines from various cell types with varying genetic background (Table 1). Here, TUSC2 is linked to non-small cell lung carcinoma.